Features
2020 Ophthalmic Telemedicine and the CMS 1135 Waiver
Changes aim to ease diagnosis and management of retinal disease.
By RIVA LEE ASBELL
Targeting RNA for Retinal Disease
RNA-based gene therapy is primed for a resurgence in retina.
By Michael Gemayel, MD, Thomas A. Ciulla, MD, MBA
Management of and Controversies in Autoimmune Retinopathy
Controversy lingers around diagnosis.
By DAVID R.P. ALMEIDA, MD, MBA, PHD, Eric K. Chin, MD, and
Covering Call for Pediatric Retina Patients
Establishing a pediatric retina call service.
By Cagri G. Besirli, MD, PhD, Vaidehi S. Dedania, MD
Web Exclusives
Industry Opportunities for Retina Specialists
Personal perspectives on transitioning to careers in the corporate world.
By Susan L. Worley, contributing writer
Departments
Disorganization of the Retinal Inner Layers as a Prognostic Biomarker
This OCT biomarker has potential importance across multiple retinal pathologies.
By Archana Nair, MD, Yasha Modi, MD
Pharmacotherapy as an Adjunct to Vitrectomy for Retinal Disease
Pharmacotherapy remains a critical component in the management of complex retinal disease.
By Veronica Kon Graversen, MD, Aaron Gold, OD, Timothy G. Murray, MD, MBA, FACS
UPFRONT: A New World of Communication and Education in Retina
By Peter K. Kaiser, MD
FUTURE FILE: Highlighting innovative early-stage and preclinical concepts in retina
By Jerry Helzner, contributing editor
NEW PRODUCT APPLICATIONS: Registry Offers Resources to Inherited Retinal Disease Patients
Offerings include genetic testing and counseling, notifications of clinical studies, and more
By Karen Appold, contributing writer
News
New Updates on Gene-Derived Anti-VEGF
Adverum and Regenxbio continue to report positive early results.
By Jerry Helzner, contributing editor
SUBSPECIALTY NEWS: Coronavirus impact on industry, clinical trials, and retina practice.
By Jerry Helzner, contributing editor